Impact of lowering triglycerides on raising HDL-C in hypertriglyceridemic and non-hypertriglyceridemic subjects

International Journal of Cardiology

Volumn 119, Issue 2, 2007, Pages 192-195

  Miller, Michael ^a   Langenberg, Patricia ^a   Havas, Stephen ^b  

^a UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

^b AMERICAN MEDICAL ASSOCIATION   (United States)

Author keywords

HDL C; Preventive cardiology; Triglycerides

Indexed keywords

BILE ACID; FIBRIC ACID DERIVATIVE; FISH OIL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NICOTINIC ACID; TRIACYLGLYCEROL;

ARTICLE; CHOLESTEROL BLOOD LEVEL; CORRELATION ANALYSIS; DIETARY INTAKE; DISEASE ASSOCIATION; EXERCISE; FEMALE; HUMAN; HYPERTRIGLYCERIDEMIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ALCOHOL DRINKING; ANTILIPEMIC AGENTS; BODY MASS INDEX; CHOLESTEROL, HDL; DIET; EXERCISE; FEMALE; HUMANS; HYPERTRIGLYCERIDEMIA; MALE; MIDDLE AGED; NIACIN; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SMOKING; TRIGLYCERIDES;

EID: 34249694670     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2006.07.132     Document Type: Article

References (18)

1. Boden W.E. High-density lipoprotein cholesterol as an independent risk factor in cardiovascular disease: assessing the data from Framingham to the Veterans Affairs High-density Lipoprotein Intervention Trial. Am J Cardiol 86 (2000) 19L-22L
2. Assmann G. Pro and con: high-density lipoprotein, triglycerides, and other lipid subfractions are the future of lipid management. Am J Cardiol 87 (2001) 2B-7B
3. Brewer Jr. H.B. Hypertriglyceridemia: changes in the plasma lipoproteins associated with an increased risk of cardiovascular disease. Am J Cardiol 83 (1999) 3F-12F
4. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 285 (2001) 2486-2497
5. Miller M., Bachorik P.S., McCrindle B.W., and Kwiterovich Jr. P.O. Effect of gemfibrozil in men with primary isolated low high-density lipoprotein cholesterol: a randomized, double-blind, placebo-controlled, crossover study. Am J Med 94 (1993) 7-12
6. Friedewald W.T., Levy R.I., and Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18 (1972) 499-502
7. Schaefer E.J., Levy R.I., Anderson D.W., Danner R.N., Brewer Jr. H.B., and Blackwelder W.C. Plasma-triglycerides in regulation of H.D.L.-cholesterol levels. Lancet 2 8086 (1978) 391-393
8. Lamarche B., Rashid S., and Lewis G.F. HDL metabolism in hypertriglyceridemic states: an overview. Clin Chim Acta 286 (1999) 145-161
9. Chen C., and Loo G. Inhibition of lecithin: cholesterol acyltransferase activity in human blood plasma by cigarette smoke extract and reactive aldehydes. J Biochem Toxicol 10 (1995) 121-128
10. Miller M., and Zhan M. Genetic determinants of low high-density lipoprotein cholesterol. Curr Opin Cardiol 19 (2004) 380-384
11. Guerin M., Dolphin P.J., Talussot C., et al. Pravastatin modulates cholesteryl ester transfer from HDL to apoB-containing lipoproteins and lipoprotein subspecies profile in familial hypercholesterolemia. Arterioscler Thromb Vasc Biol 15 (1995) 1359-1368
12. Rosenson R.S. Antiatherothrombotic effects of nicotinic acid. Atherosclerosis 171 (2003) 87-96
13. Staels B., Dallongeville J., Auwerx J., et al. Mechanism of action of fibrates on lipid and lipoprotein metabolism. Circulation 98 (1998) 2088-2093
14. Duez H., Lefebvre B., Poulain P., et al. Regulation of human apoA-I by gemfibrozil and fenofibrate through selective peroxisome proliferator-activated receptor alpha modulation. Arterioscler Thromb Vasc Biol 25 (2005) 585-591
15. Sacks F.M., and Katan M. Randomized clinical trials on the effects of dietary fat and carbohydrate on plasma lipoproteins and cardiovascular disease. Am J Med 113 Suppl 9B (2002) 13S-24S
16. Williams P.T., Wood P.D., Krauss R.M., et al. Does weight loss cause the exercise-induced increase in plasma high density lipoproteins?. Atherosclerosis 47 (1983) 173-185
17. Mokdad A.H., Serdula M.K., Dietz W.H., et al. The spread of the obesity epidemic in the United States, 1991-1998. JAMA 282 (1999) 1519-1522
18. Marniemi J., Maki J., Maatela J., Jarvisalo J., and Impivaara O. Poor applicability of the Friedewald formula in the assessment of serum LDL cholesterol for clinical purposes. Clin Biochem 28 (1995) 285-289